Flu (Influenza) Vaccine Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Flu (Influenza) Vaccine in global, including the following market information:
Global Flu (Influenza) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Flu (Influenza) Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Flu (Influenza) Vaccine companies in 2021 (%)
The global Flu (Influenza) Vaccine market was valued at 5664.4 million in 2021 and is projected to reach US$ 7707.3 million by 2028, at a CAGR of 4.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Split Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Flu (Influenza) Vaccine include Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological and SIOBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu (Influenza) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu (Influenza) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Flu (Influenza) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Flu (Influenza) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Flu (Influenza) Vaccine revenues share in global market, 2021 (%)
Key companies Flu (Influenza) Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Flu (Influenza) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Flu (Influenza) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Flu (Influenza) Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Flu (Influenza) Vaccine companies in 2021 (%)
The global Flu (Influenza) Vaccine market was valued at 5664.4 million in 2021 and is projected to reach US$ 7707.3 million by 2028, at a CAGR of 4.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Split Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Flu (Influenza) Vaccine include Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological and SIOBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu (Influenza) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu (Influenza) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Type, 2021 (%)
- Split Influenza Vaccine
- Pandemic Influenza Vaccine
- Subunit Influenza Vaccine
- Quadrivalent Influenza Vaccine
Global Flu (Influenza) Vaccine Market Segment Percentages, by Application, 2021 (%)
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
Global Flu (Influenza) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Flu (Influenza) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Flu (Influenza) Vaccine revenues share in global market, 2021 (%)
Key companies Flu (Influenza) Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Flu (Influenza) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Hualan Bio
- CCBIO
- Aleph Biomedical
- SANOFI
- Adimmune
- ZYAK
- SINOVAC
- Changsheng Biological
- SIOBP
- GSK
- Aimei Hissen
- Tianyuan Bio-pharma(Novartis)
- Simcere Vaxtec
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Flu (Influenza) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu (Influenza) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FLU (INFLUENZA) VACCINE OVERALL MARKET SIZE
2.1 Global Flu (Influenza) Vaccine Market Size: 2021 VS 2028
2.2 Global Flu (Influenza) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Flu (Influenza) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Flu (Influenza) Vaccine Players in Global Market
3.2 Top Global Flu (Influenza) Vaccine Companies Ranked by Revenue
3.3 Global Flu (Influenza) Vaccine Revenue by Companies
3.4 Global Flu (Influenza) Vaccine Sales by Companies
3.5 Global Flu (Influenza) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Flu (Influenza) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Flu (Influenza) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu (Influenza) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Flu (Influenza) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Flu (Influenza) Vaccine Market Size Markets, 2021 & 2028
4.1.2 Split Influenza Vaccine
4.1.3 Pandemic Influenza Vaccine
4.1.4 Subunit Influenza Vaccine
4.1.5 Quadrivalent Influenza Vaccine
4.2 By Type - Global Flu (Influenza) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Flu (Influenza) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Flu (Influenza) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Flu (Influenza) Vaccine Sales & Forecasts
4.3.1 By Type - Global Flu (Influenza) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Flu (Influenza) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Flu (Influenza) Vaccine Market Size, 2021 & 2028
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Flu (Influenza) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Flu (Influenza) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Flu (Influenza) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Flu (Influenza) Vaccine Sales & Forecasts
5.3.1 By Application - Global Flu (Influenza) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Flu (Influenza) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Flu (Influenza) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Flu (Influenza) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Flu (Influenza) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Flu (Influenza) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Flu (Influenza) Vaccine Sales & Forecasts
6.3.1 By Region - Global Flu (Influenza) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Flu (Influenza) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Flu (Influenza) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Flu (Influenza) Vaccine Sales, 2017-2028
6.4.3 US Flu (Influenza) Vaccine Market Size, 2017-2028
6.4.4 Canada Flu (Influenza) Vaccine Market Size, 2017-2028
6.4.5 Mexico Flu (Influenza) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Flu (Influenza) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Flu (Influenza) Vaccine Sales, 2017-2028
6.5.3 Germany Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.4 France Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.5 U.K. Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.6 Italy Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.7 Russia Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.9 Benelux Flu (Influenza) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Flu (Influenza) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Flu (Influenza) Vaccine Sales, 2017-2028
6.6.3 China Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.4 Japan Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.5 South Korea Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.7 India Flu (Influenza) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Flu (Influenza) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Flu (Influenza) Vaccine Sales, 2017-2028
6.7.3 Brazil Flu (Influenza) Vaccine Market Size, 2017-2028
6.7.4 Argentina Flu (Influenza) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, 2017-2028
6.8.3 Turkey Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.4 Israel Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.6 UAE Flu (Influenza) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Hualan Bio
7.1.1 Hualan Bio Corporate Summary
7.1.2 Hualan Bio Business Overview
7.1.3 Hualan Bio Flu (Influenza) Vaccine Major Product Offerings
7.1.4 Hualan Bio Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Hualan Bio Key News
7.2 CCBIO
7.2.1 CCBIO Corporate Summary
7.2.2 CCBIO Business Overview
7.2.3 CCBIO Flu (Influenza) Vaccine Major Product Offerings
7.2.4 CCBIO Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CCBIO Key News
7.3 Aleph Biomedical
7.3.1 Aleph Biomedical Corporate Summary
7.3.2 Aleph Biomedical Business Overview
7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Major Product Offerings
7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Aleph Biomedical Key News
7.4 SANOFI
7.4.1 SANOFI Corporate Summary
7.4.2 SANOFI Business Overview
7.4.3 SANOFI Flu (Influenza) Vaccine Major Product Offerings
7.4.4 SANOFI Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 SANOFI Key News
7.5 Adimmune
7.5.1 Adimmune Corporate Summary
7.5.2 Adimmune Business Overview
7.5.3 Adimmune Flu (Influenza) Vaccine Major Product Offerings
7.5.4 Adimmune Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Adimmune Key News
7.6 ZYAK
7.6.1 ZYAK Corporate Summary
7.6.2 ZYAK Business Overview
7.6.3 ZYAK Flu (Influenza) Vaccine Major Product Offerings
7.6.4 ZYAK Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 ZYAK Key News
7.7 SINOVAC
7.7.1 SINOVAC Corporate Summary
7.7.2 SINOVAC Business Overview
7.7.3 SINOVAC Flu (Influenza) Vaccine Major Product Offerings
7.7.4 SINOVAC Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 SINOVAC Key News
7.8 Changsheng Biological
7.8.1 Changsheng Biological Corporate Summary
7.8.2 Changsheng Biological Business Overview
7.8.3 Changsheng Biological Flu (Influenza) Vaccine Major Product Offerings
7.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Changsheng Biological Key News
7.9 SIOBP
7.9.1 SIOBP Corporate Summary
7.9.2 SIOBP Business Overview
7.9.3 SIOBP Flu (Influenza) Vaccine Major Product Offerings
7.9.4 SIOBP Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 SIOBP Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Flu (Influenza) Vaccine Major Product Offerings
7.10.4 GSK Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 Aimei Hissen
7.11.1 Aimei Hissen Corporate Summary
7.11.2 Aimei Hissen Flu (Influenza) Vaccine Business Overview
7.11.3 Aimei Hissen Flu (Influenza) Vaccine Major Product Offerings
7.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Aimei Hissen Key News
7.12 Tianyuan Bio-pharma(Novartis)
7.12.1 Tianyuan Bio-pharma(Novartis) Corporate Summary
7.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Business Overview
7.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Major Product Offerings
7.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Tianyuan Bio-pharma(Novartis) Key News
7.13 Simcere Vaxtec
7.13.1 Simcere Vaxtec Corporate Summary
7.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Business Overview
7.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Major Product Offerings
7.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Simcere Vaxtec Key News
8 GLOBAL FLU (INFLUENZA) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Flu (Influenza) Vaccine Production Capacity, 2017-2028
8.2 Flu (Influenza) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu (Influenza) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FLU (INFLUENZA) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Flu (Influenza) Vaccine Industry Value Chain
10.2 Flu (Influenza) Vaccine Upstream Market
10.3 Flu (Influenza) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu (Influenza) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Flu (Influenza) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu (Influenza) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FLU (INFLUENZA) VACCINE OVERALL MARKET SIZE
2.1 Global Flu (Influenza) Vaccine Market Size: 2021 VS 2028
2.2 Global Flu (Influenza) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Flu (Influenza) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Flu (Influenza) Vaccine Players in Global Market
3.2 Top Global Flu (Influenza) Vaccine Companies Ranked by Revenue
3.3 Global Flu (Influenza) Vaccine Revenue by Companies
3.4 Global Flu (Influenza) Vaccine Sales by Companies
3.5 Global Flu (Influenza) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Flu (Influenza) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Flu (Influenza) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu (Influenza) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Flu (Influenza) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Flu (Influenza) Vaccine Market Size Markets, 2021 & 2028
4.1.2 Split Influenza Vaccine
4.1.3 Pandemic Influenza Vaccine
4.1.4 Subunit Influenza Vaccine
4.1.5 Quadrivalent Influenza Vaccine
4.2 By Type - Global Flu (Influenza) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Flu (Influenza) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Flu (Influenza) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Flu (Influenza) Vaccine Sales & Forecasts
4.3.1 By Type - Global Flu (Influenza) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Flu (Influenza) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Flu (Influenza) Vaccine Market Size, 2021 & 2028
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Flu (Influenza) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Flu (Influenza) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Flu (Influenza) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Flu (Influenza) Vaccine Sales & Forecasts
5.3.1 By Application - Global Flu (Influenza) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Flu (Influenza) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Flu (Influenza) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Flu (Influenza) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Flu (Influenza) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Flu (Influenza) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Flu (Influenza) Vaccine Sales & Forecasts
6.3.1 By Region - Global Flu (Influenza) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Flu (Influenza) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Flu (Influenza) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Flu (Influenza) Vaccine Sales, 2017-2028
6.4.3 US Flu (Influenza) Vaccine Market Size, 2017-2028
6.4.4 Canada Flu (Influenza) Vaccine Market Size, 2017-2028
6.4.5 Mexico Flu (Influenza) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Flu (Influenza) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Flu (Influenza) Vaccine Sales, 2017-2028
6.5.3 Germany Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.4 France Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.5 U.K. Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.6 Italy Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.7 Russia Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Flu (Influenza) Vaccine Market Size, 2017-2028
6.5.9 Benelux Flu (Influenza) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Flu (Influenza) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Flu (Influenza) Vaccine Sales, 2017-2028
6.6.3 China Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.4 Japan Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.5 South Korea Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Flu (Influenza) Vaccine Market Size, 2017-2028
6.6.7 India Flu (Influenza) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Flu (Influenza) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Flu (Influenza) Vaccine Sales, 2017-2028
6.7.3 Brazil Flu (Influenza) Vaccine Market Size, 2017-2028
6.7.4 Argentina Flu (Influenza) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, 2017-2028
6.8.3 Turkey Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.4 Israel Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Flu (Influenza) Vaccine Market Size, 2017-2028
6.8.6 UAE Flu (Influenza) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Hualan Bio
7.1.1 Hualan Bio Corporate Summary
7.1.2 Hualan Bio Business Overview
7.1.3 Hualan Bio Flu (Influenza) Vaccine Major Product Offerings
7.1.4 Hualan Bio Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Hualan Bio Key News
7.2 CCBIO
7.2.1 CCBIO Corporate Summary
7.2.2 CCBIO Business Overview
7.2.3 CCBIO Flu (Influenza) Vaccine Major Product Offerings
7.2.4 CCBIO Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CCBIO Key News
7.3 Aleph Biomedical
7.3.1 Aleph Biomedical Corporate Summary
7.3.2 Aleph Biomedical Business Overview
7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Major Product Offerings
7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Aleph Biomedical Key News
7.4 SANOFI
7.4.1 SANOFI Corporate Summary
7.4.2 SANOFI Business Overview
7.4.3 SANOFI Flu (Influenza) Vaccine Major Product Offerings
7.4.4 SANOFI Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 SANOFI Key News
7.5 Adimmune
7.5.1 Adimmune Corporate Summary
7.5.2 Adimmune Business Overview
7.5.3 Adimmune Flu (Influenza) Vaccine Major Product Offerings
7.5.4 Adimmune Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Adimmune Key News
7.6 ZYAK
7.6.1 ZYAK Corporate Summary
7.6.2 ZYAK Business Overview
7.6.3 ZYAK Flu (Influenza) Vaccine Major Product Offerings
7.6.4 ZYAK Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 ZYAK Key News
7.7 SINOVAC
7.7.1 SINOVAC Corporate Summary
7.7.2 SINOVAC Business Overview
7.7.3 SINOVAC Flu (Influenza) Vaccine Major Product Offerings
7.7.4 SINOVAC Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 SINOVAC Key News
7.8 Changsheng Biological
7.8.1 Changsheng Biological Corporate Summary
7.8.2 Changsheng Biological Business Overview
7.8.3 Changsheng Biological Flu (Influenza) Vaccine Major Product Offerings
7.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Changsheng Biological Key News
7.9 SIOBP
7.9.1 SIOBP Corporate Summary
7.9.2 SIOBP Business Overview
7.9.3 SIOBP Flu (Influenza) Vaccine Major Product Offerings
7.9.4 SIOBP Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 SIOBP Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Flu (Influenza) Vaccine Major Product Offerings
7.10.4 GSK Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 GSK Key News
7.11 Aimei Hissen
7.11.1 Aimei Hissen Corporate Summary
7.11.2 Aimei Hissen Flu (Influenza) Vaccine Business Overview
7.11.3 Aimei Hissen Flu (Influenza) Vaccine Major Product Offerings
7.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Aimei Hissen Key News
7.12 Tianyuan Bio-pharma(Novartis)
7.12.1 Tianyuan Bio-pharma(Novartis) Corporate Summary
7.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Business Overview
7.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Major Product Offerings
7.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Tianyuan Bio-pharma(Novartis) Key News
7.13 Simcere Vaxtec
7.13.1 Simcere Vaxtec Corporate Summary
7.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Business Overview
7.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Major Product Offerings
7.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Simcere Vaxtec Key News
8 GLOBAL FLU (INFLUENZA) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Flu (Influenza) Vaccine Production Capacity, 2017-2028
8.2 Flu (Influenza) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu (Influenza) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FLU (INFLUENZA) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Flu (Influenza) Vaccine Industry Value Chain
10.2 Flu (Influenza) Vaccine Upstream Market
10.3 Flu (Influenza) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu (Influenza) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Flu (Influenza) Vaccine in Global Market
Table 2. Top Flu (Influenza) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Flu (Influenza) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Flu (Influenza) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Flu (Influenza) Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Flu (Influenza) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Flu (Influenza) Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Flu (Influenza) Vaccine Product Type
Table 9. List of Global Tier 1 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 46. Hualan Bio Corporate Summary
Table 47. Hualan Bio Flu (Influenza) Vaccine Product Offerings
Table 48. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CCBIO Corporate Summary
Table 50. CCBIO Flu (Influenza) Vaccine Product Offerings
Table 51. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Aleph Biomedical Corporate Summary
Table 53. Aleph Biomedical Flu (Influenza) Vaccine Product Offerings
Table 54. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. SANOFI Corporate Summary
Table 56. SANOFI Flu (Influenza) Vaccine Product Offerings
Table 57. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Adimmune Corporate Summary
Table 59. Adimmune Flu (Influenza) Vaccine Product Offerings
Table 60. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. ZYAK Corporate Summary
Table 62. ZYAK Flu (Influenza) Vaccine Product Offerings
Table 63. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. SINOVAC Corporate Summary
Table 65. SINOVAC Flu (Influenza) Vaccine Product Offerings
Table 66. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Changsheng Biological Corporate Summary
Table 68. Changsheng Biological Flu (Influenza) Vaccine Product Offerings
Table 69. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. SIOBP Corporate Summary
Table 71. SIOBP Flu (Influenza) Vaccine Product Offerings
Table 72. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Flu (Influenza) Vaccine Product Offerings
Table 75. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Aimei Hissen Corporate Summary
Table 77. Aimei Hissen Flu (Influenza) Vaccine Product Offerings
Table 78. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Tianyuan Bio-pharma(Novartis) Corporate Summary
Table 80. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Offerings
Table 81. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Simcere Vaxtec Corporate Summary
Table 83. Simcere Vaxtec Flu (Influenza) Vaccine Product Offerings
Table 84. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Flu (Influenza) Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Flu (Influenza) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Flu (Influenza) Vaccine Production by Region, 2017-2022 (K Units)
Table 88. Global Flu (Influenza) Vaccine Production by Region, 2023-2028 (K Units)
Table 89. Flu (Influenza) Vaccine Market Opportunities & Trends in Global Market
Table 90. Flu (Influenza) Vaccine Market Drivers in Global Market
Table 91. Flu (Influenza) Vaccine Market Restraints in Global Market
Table 92. Flu (Influenza) Vaccine Raw Materials
Table 93. Flu (Influenza) Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Flu (Influenza) Vaccine Downstream
Table 95. Flu (Influenza) Vaccine Downstream Clients in Global Market
Table 96. Flu (Influenza) Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Flu (Influenza) Vaccine in Global Market
Table 2. Top Flu (Influenza) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Flu (Influenza) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Flu (Influenza) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Flu (Influenza) Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Flu (Influenza) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Flu (Influenza) Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Flu (Influenza) Vaccine Product Type
Table 9. List of Global Tier 1 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2023-2028
Table 46. Hualan Bio Corporate Summary
Table 47. Hualan Bio Flu (Influenza) Vaccine Product Offerings
Table 48. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CCBIO Corporate Summary
Table 50. CCBIO Flu (Influenza) Vaccine Product Offerings
Table 51. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Aleph Biomedical Corporate Summary
Table 53. Aleph Biomedical Flu (Influenza) Vaccine Product Offerings
Table 54. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. SANOFI Corporate Summary
Table 56. SANOFI Flu (Influenza) Vaccine Product Offerings
Table 57. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Adimmune Corporate Summary
Table 59. Adimmune Flu (Influenza) Vaccine Product Offerings
Table 60. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. ZYAK Corporate Summary
Table 62. ZYAK Flu (Influenza) Vaccine Product Offerings
Table 63. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. SINOVAC Corporate Summary
Table 65. SINOVAC Flu (Influenza) Vaccine Product Offerings
Table 66. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Changsheng Biological Corporate Summary
Table 68. Changsheng Biological Flu (Influenza) Vaccine Product Offerings
Table 69. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. SIOBP Corporate Summary
Table 71. SIOBP Flu (Influenza) Vaccine Product Offerings
Table 72. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GSK Corporate Summary
Table 74. GSK Flu (Influenza) Vaccine Product Offerings
Table 75. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Aimei Hissen Corporate Summary
Table 77. Aimei Hissen Flu (Influenza) Vaccine Product Offerings
Table 78. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Tianyuan Bio-pharma(Novartis) Corporate Summary
Table 80. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Offerings
Table 81. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Simcere Vaxtec Corporate Summary
Table 83. Simcere Vaxtec Flu (Influenza) Vaccine Product Offerings
Table 84. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Flu (Influenza) Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Flu (Influenza) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Flu (Influenza) Vaccine Production by Region, 2017-2022 (K Units)
Table 88. Global Flu (Influenza) Vaccine Production by Region, 2023-2028 (K Units)
Table 89. Flu (Influenza) Vaccine Market Opportunities & Trends in Global Market
Table 90. Flu (Influenza) Vaccine Market Drivers in Global Market
Table 91. Flu (Influenza) Vaccine Market Restraints in Global Market
Table 92. Flu (Influenza) Vaccine Raw Materials
Table 93. Flu (Influenza) Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Flu (Influenza) Vaccine Downstream
Table 95. Flu (Influenza) Vaccine Downstream Clients in Global Market
Table 96. Flu (Influenza) Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Flu (Influenza) Vaccine Segment by Type
Figure 2. Flu (Influenza) Vaccine Segment by Application
Figure 3. Global Flu (Influenza) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Flu (Influenza) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Flu (Influenza) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Flu (Influenza) Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu (Influenza) Vaccine Revenue in 2021
Figure 9. By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Flu (Influenza) Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Flu (Influenza) Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 19. US Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 33. China Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Flu (Influenza) Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Flu (Influenza) Vaccine by Region, 2021 VS 2028
Figure 50. Flu (Influenza) Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Flu (Influenza) Vaccine Segment by Type
Figure 2. Flu (Influenza) Vaccine Segment by Application
Figure 3. Global Flu (Influenza) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Flu (Influenza) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Flu (Influenza) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Flu (Influenza) Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu (Influenza) Vaccine Revenue in 2021
Figure 9. By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Flu (Influenza) Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Flu (Influenza) Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 19. US Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 33. China Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Flu (Influenza) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Flu (Influenza) Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Flu (Influenza) Vaccine by Region, 2021 VS 2028
Figure 50. Flu (Influenza) Vaccine Industry Value Chain
Figure 51. Marketing Channels
